Scilex Holding Co share price logo

Scilex Holding Co Share Price

NASDAQ: SCLX

Small Cap

$7.33

-0.47

(-6.03%)

as on

Scilex Holding Co Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $7.28
    $7.83
    downward going graph

    0.68%

    Downside

    6.82%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.60
    $34.27
    downward going graph

    50.89%

    Downside

    367.53%

    Upside

    downward going graph

Scilex Holding Co share price movements today

Previous Close
$7.80
Open
$7.80
Volume
339.7K
Day's Low - High
$7.28 - $7.83
52 Week Low - High
$3.60 - $34.27

Scilex Holding Co Historical Returns

1 Month Return
-7.39 %
3 Month Return
-47.6 %
1 Year Return
-23.29 %
3 Year Return
-97.39 %
5 Year Return
0 %

Scilex Holding Co Stock Fundamentals & Key Indicators

Check Scilex Holding Co market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$54.9M

EPS (TTM)

-32.32

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.79

Industry PE ratio

0

PEG Ratio

0

EBITDA

-259.2M

Revenue (TTM)

40.4M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Scilex Holding Co Stock Valuation

Track how Scilex Holding Co P/E has moved over time to understand its valuation trends.

Scilex Holding Co in the last 5 years

  • Overview

  • Trends

Lowest (-39.99x)

June 30, 2023

Industry (0.00x)

March 21, 2026

Today (-1.79x)

March 21, 2026

Highest (-0.40x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.79x

Scilex Holding Co vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Scilex Holding Co with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Scilex Holding Co image
Scilex Holding Co
BUY$54.9MNA-1.790.00%
ASTRAZENECA PLC image
ASTRAZENECA PLC
BUY$292.9B273.09%28.8917.41%
Eli Lilly And Company image
Eli Lilly And Company
BUY$821.2B392%39.9831.67%
Johnson & Johnson image
Johnson & Johnson
BUY$572.6B47.07%21.5628.46%
Abbvie Inc image
Abbvie Inc
BUY$364.6B98.29%87.026.91%
See all

Stock Returns calculator for Scilex Holding Co Stock including INR - Dollar returns

The Scilex Holding Co stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Scilex Holding Co investment value today

Current value as on today

₹84,241

Returns

₹15,759

(-15.76%)

Returns from Scilex Holding Co Stock

₹25,204 (-25.2%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Scilex Holding Co Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Scilex Holding Co. Average target price of $490

Scilex Holding Co Share Price Target

Get share price movements and forecasts by analysts on Scilex Holding Co.

What analysts predicted

98.5%UPSIDE

Target Price

$490

Current Price

$7.33

Analyzed by

8 Analysts

Target

$490.00

Scilex Holding Co target price $490, a slight upside of 98.5% compared to current price of $7.33. According to 8 analysts rating.

Scilex Holding Co Stock’s Investor Sentiment and Interest

Search interest for Scilex Holding Co Stock has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-64% versus previous 30 day period

Scilex Holding Co Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
12
10
13
10
16
14
14
5
9
10
Gross Profit
8
6
7
7
11
10
10
3
6
7
Operating Income
-22
-38
-18
-19
-15
-22
-28
-27
-20
-186
EBITDA
-25
-33
-19
-22
-36
-
-5
-22
-40
-253
Interest Expense
0
0
0
0
0
0
0
2
2
2
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-26
-35
-21
-24
-37
-4
-6
-26
-44
-257
Income Tax Expense
0
0
0
0
-
-
0
0
0
0
Net Income
-26
-35
-21
-24
-37
-4
-6
-26
-86
-257
Net Profit Margin
-211.80%
-351.18%
-158.97%
-223.97%
-229.58%
-30.40%
-43.36%
-521.18%
-869.65%
-2435.93%

Scilex Holding Co Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
21
23
31
38
46
56
Gross Profit
15
21
27
27
31
39
Operating Income
-138
-35
-35
-50
-105
-83
EBITDA
-157
-31
-72
-9
-109
-66
Interest Expense
16
13
11
9
1
1
Depreciation
3
3
3
3
4
4
Income Before Tax
-178
-47
-88
-23
-114
-72
Income Tax Expense
0
0
0
0
0
0
Net Income
-178
-47
-88
-23
-114
-72
Net Profit Margin
-849.11%
-201.69%
-282.35%
-61.43%
-244.59%
-128.66%

Scilex Holding Co Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-35
-21
-24
-37
-4
-6
-26
-44
-257
Operating Cash Flow
5
-5
9
2
5
2
6
7
8
Investing Cash Flow
0
0
0
0
-
0
0
0
0
Financing Cash Flow
-38
8
-11
4
-4
-7
-3
-8
-11
Change in Cash
-33
1
-1
6
-1
-4
2
-1
-3

Scilex Holding Co Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-47
-88
-23
-114
-72
Operating Cash Flow
-31
-28
-21
-20
19
Investing Cash Flow
0
-139
-2
0
-2
Financing Cash Flow
-19
28
21
23
-18
Change in Cash
-50
0
-2
2
-1

Global Institutional Holdings in Scilex Holding Co

Funds
Holdings
BlackRock Inc
1.4%
UBS Group AG
0.36%
BNP Paribas Arbitrage, SA
0.04%
Qube Research & Technologies
0.16%
Deutsche Bank AG
0.01%
See all

Insights on Scilex Holding Co

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 5.00M → 10.56M (in $), with an average increase of 27.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, ASTRAZENECA PLC has given 175.8% return, outperforming this stock by 273.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, ASTRAZENECA PLC has given 145.0% return, outperforming this stock by 168.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, SCLX stock has moved down by -47.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 5 quarters, -4.38M → -257.23M (in $), with an average decrease of 195.0% per quarter

About Scilex Holding Co

Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.
OrganisationScilex Holding Co
Headquarters960 San Antonio Road, Palo Alto, CA, United States, 94303
IndustryHealthcare
CEODr. Henry H. Ji Ph.D.
E-voting on sharesClick here to vote

Key Management of Scilex Holding Co

Name

Title

Dr. Suketu D. Desai Ph.D.

Interim Chief Technical Officer & Senior VP

Ms. Gigi DeGuzman

VP & Chief People Officer

Mr. Suresh K. Khemani

Senior VP, Chief Commercial Officer & GM of Scilex Pharma

Dr. Dmitri V. Lissin M.D.

Senior VP of Clinical Development and Medical Affairs & Interim Chief Medical Officer

Dr. Henry H. Ji Ph.D.

CEO, President & Executive Chairman

Mr. Stephen Ma

Senior VP, CFO, COO, Corporate Secretary & Director

FAQs

What is Scilex Holding Co share price today?

Scilex Holding Co share price today is $7.33 as on at the close of the market. Scilex Holding Co share today touched a day high of $7.83 and a low of $7.28.

What is the 52 week high and 52 week low for Scilex Holding Co share?

Scilex Holding Co share touched a 52 week high of $34.27 on and a 52 week low of $3.6 on . Scilex Holding Co stock price today i.e. is closed at $7.33,which is 78.61% down from its 52 week high and 103.61% up from its 52 week low.

What is Scilex Holding Co's market capitalisation today?

Scilex Holding Co market capitalisation is $0.00T as on .

How to invest in Scilex Holding Co Stock (SCLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Scilex Holding Co on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Scilex Holding Co Shares that will get you 0.2046 shares as per Scilex Holding Co share price of $7.33 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Scilex Holding Co Stock (SCLX) from India?

Indian investors can start investing in Scilex Holding Co (SCLX) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Scilex Holding Co stock (as per the Rupee-Dollar exchange rate as on ). Based on Scilex Holding Co share’s latest price of $7.33 as on March 21, 2026 at 1:29 am IST, you will get 1.3643 shares of Scilex Holding Co. Learn more about fractional shares .